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Introduction
Neisseria meningitidis is a gram negative bacterium which 
is hosted solely by the man. Usually, the microrganism, 
that finds its habitat in the nasopharynx, can live with the 
human body without causing damage. Indeed, N. men-
ingitidis to adapt itself to survive in human body should 
find equilibrium with its exclusive host. In other terms, 
meningococcus should pursue the aim to reach almost a 
symbiotic coexistence with the humans. Indeed, the dis-
ease is almost an exception, and the rule is that the bacte-
rium survives in rhinopharynx for a limited period of time. 
Consequently the number of carriers of meningococcus is 
very higher than the number of meningitis cases.
However, sometimes, because of its own characteristics 
of virulence or because of weak conditions of the hu-
man body, meningococcus can cause devastating conse-
quences, such as meningitis, sepsis, and the Waterhause-
Friederiksen’s syndrome [1].
As other bacteria, in nature, meningococcus is continu-
ally subjected to unfavourable environmental conditions 
of life. The adaptation, under such difficult conditions, 
requires to meningococcus to implement many survival 
strategies [2].
The most important human defence against the bacterial 
colonization is the immune-system. Indeed, the innate 
immune response ensures immediate protection irrespec-
tive by the antigen, and it is realized through epithelial 
and phagocytic cells, together with the complement and 
substances with antimicrobial action. Later, when adap-
tive immunity also operates, the bacteria are cleared [3]. 
Infants come in contact early with different members of 
Neisseriaceae family bacteria, and the first contact is the 
more dangerous [4]. Subsequent contacts help the infant 
to mount an immunological response, which has sev-
eral fluctuations during the infancy and childhood. The 
antibodies decrease during the adolescence [5], and, in 
the same time, the social life of the young facilitates the 
circulation of N. meningitidis. In the young the patho-
gen arranges the fulcrum for its survival. Indeed, in the 
young it is possible to find the highest percentages of 
carriers [6].
A genome very compact but extremely variable allows 
meningococcus to circumvent the immune defences. N. 
menigitidis has the ability to acquire genes of other bac-
teria from the environment and so generate new vari-
ants [7].
Another important defence mechanism of the meningo-
coccus is its ability to camouflage some surface struc-
tures, making them similar to substances peculiar of the 
human organism. This feature is particularly evident for 
the meningococcus of serogroup B [3].
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Summary
Neisseria meningitidis is hosted only by humans and colonizes 
the nasopharynx; it survives in the human body by reaching an 
equilibrium with its exclusive host. Indeed, while cases of invasive 
disease are rare, the number of asymptomatic Neisseria menin-
gitides carriers is far higher. The aim of this paper is to sum-
marize the current knowledge of survival strategies of Neisseria 
meningitides against the human immune defences.
Neisseria meningitidis possesses a variety of adaptive character-
istics which enable it to avoid being killed by the immune system, 
such as the capsule, the lipopolysaccharide, groups of proteins 
that block the action of the antimicrobial proteins (AMP), pro-
teins that inhibit the complement system, and components that 
prevent both the maturation and the perfect functioning of phago-
cytes. The main means of adhesion of Neisseria meningitides to 
the host cells are Pili, constituted by several proteins of whom the 
most important is Pilin E.
Opacity-associated proteins (Opa) and (Opc) are two proteins 
that make an important contribution to the process of adhesion 
to the cell. Porins A and B contribute to neisserial adhesion and 
penetration into the cells, and also inhibit the complement system. 
Factor H binding protein (fhbp) binds factor H, allowing the bac-
teria to survive in the blood. 
Neisserial adhesin A (NadA) is a minor adhesin that is expressed 
by 50% of the pathogenic strains. NadA is known to be involved 
in cell adhesion and invasion and in the induction of proinflam-
matory cytokines.
Neisserial heparin binding antigen (NHBA) binds heparin, thus 
increasing the resistance of the bacterium in the serum. 
The full article is free available on www.jpmh.org
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N. meningitidis interactions  
with the nasal mucosa cells
The most important route of meningococcal transmission 
is the contact from person-to-person through Flügge’s 
droplets from asymptomatic carriers or from persons 
with invasive disease.
Once arrived in the nasal mucosa, meningococcus prob-
ably uses various defence mechanisms, such as to remain 
aggregated to reduce the exposure of surface antigens 
and to produce a lot of outer membrane vesicles (OMV) 
to trick the human body’s defences, as IgA secretory an-
tibodies. 
At the level of epithelial barrier meningococci should 
escape several immunological defences, in particular: 
antimicrobial compounds, as for instance peptidoglycan 
recognition protein, proteins involved in iron metabo-
lism, etc, and oxygen and nitrogen species (ROS and 
RNS) produced by activated phagocytic cells. Further-
more, although less abundant than in systemic circula-
tion, complement factors are present also on the surface 
of the mucosal cells.
Although the mechanism of action of antimicrobial com-
pounds is not yet completely known, however it is prob-
able that these proteins act modifying bacterial mem-
brane stability and permeability. Antimicrobial proteins 
and peptides also bind to lipopolysaccharide (LOS/LPS) 
of Gram negative bacteria, thus neutralizing their endo-
toxic activity [3] (Fig. 1).
Subsequently, Neisseria must avoid mucus clearance, 
and so must adhere to the epithelial cells. For this goal 
meningococcus has several mechanisms of action. The 
pili are the most important Neisserial adhesins, which 
are constituted by several proteins. The most important 
is Pilin E (PilE) [8, 9], however two distinct minor pilus-
associated proteins, PilC [10], and Pil Q [11] have been 
recently described. The pili proteins are very variable. 
The cellular receptors for the interaction with Neisserial 
pili are not completely known, however, probably they 
interact with membrane co-factor protein, also known as 
CD46 receptor, and with alpha 1 and alpha 2 integrins.
N. meningitidis, usually, expresses two kinds of outer-
membrane proteins, the opacity-associated proteins Opa 
and Opc, which confer opacity to agar-grown colonies. 
Opa proteins can attach to carcinoembryonic antigen-re-
lated cell-adhesion molecule (CEACAMs), which belong 
to a family of the immunoglobulin superfamily [12, 13] 
and HSPGs (heparan sulfate proteoglycans) [14] and 
Opc proteins can interact with HSPGs and, through the 
vitronectin and fibronectin, to their integrin receptors. 
Further, minor adhesins can help the meningococcus 
to adhere to epithelial cells. These adhesin are: Neisse-
rial Adhesin A (NadA, that is expressed by 50% of the 
pathogenic strains, but only by 5% of the strains isolated 
from carriers); an OCA (oligomeric coiled-coil adhesin); 
NhhA (Neisseria hia homologue A) and App (adhesion 
and penetration protein), expressed by virulent N. men-
ingitidis strains, whereas MspA (meningococcal serine 
protease A), that is an homologous of App, is only some-
times expressed by virulent strains [8].
Penetration and colonization  
of the respiratory mucosa
Recently, it has been demostrate that Opc is able to bind 
to the α-actinin cytoskeletal protein of both epithelial 
and endothelial cells [15]. To cross the epithelial barrier, 
meningococci interact with the extracellular matrix pro-
teins, both the fibronectin (Fn) and the vitronectin (Vn). 
Furthermore, it is possible that minor adhesins are able 
to help bacterial invasion of the mucosal barriers. 
When N. meningitidis reaches sub-epithelial tissues is 
widely exposed to immunologic cells. In particular to 
dendritic, macrophage, and neutrophil cells. 
Dendritic cells (DCs) have important functions in an-
tigen presentation and in immune-homoeostasis [16]. 
These cells are also very important to initiate adaptive 
immune responses. Both at mucosal surfaces and, over-
all, in sub-epithelial tissues, these cells govern responses 
both to pathogenic and commensal bacteria. They have 
a crucial importance in the mechanisms for distinguish 
microrganisms that must eliminating or tolerating [16]. 
Activated DCs secrete many cytokines, as: IFNγ and IL-
12 (which activate the Killer cells; IL-12, also, activate 
naïve CD4- cells), IL-6 and 23 (which stimulate Th1 
cells to secrete IFNγ, TFN, and lymphotoxins; IL-6, also, 
activate Th2 cells to secrete IL-4, IL-5, IL-13 and IFN-
alpha). As other cells of the immune system DCs can be 
activated via Toll-Like-Receptors (TLRs). Until now, at 
least TLR 2, 3, 4, 5, 6, 7, 8, 9 and 10 have been identified 
on the surface of DCs. Further, also macrophages have 
many TLRs. In particular TLR 4 appears to be activated 
by Neisserial antigens, especially by lipo(oligo)saccha-
ride (LOS). After the activation via TLR4, macrophages 
release: cytokines, chemokines, nitric oxide, and ROS.
Experiments in vitro have shown that dendritic cells are 
able to kill wild-type N. meningitidis strains [17]. How-
ever, it has been demonstrated that encapsulated, wild-
type N. meningitidis have a lower capacity to adhere 
to dendritic cells than unencapsulated strains [17, 18]. 
Further, lipopolysaccharide sialylation inhibits phago-
cytosis [18, 19]. Thus, even if capsule expression is 
low, the bacterium could be still protected from den-
dritic-cell phagocytosis [3]. More recently, it has been 
demonstrated that live meningococci is able to interfere 
with maturation of DCs [20]. Thus N. meningitidis can 
prevent the development of an effective cellular and 
humoral immune response. Furthermore, in the lamina 
propria of the mucosa, meningococcus is able to escape 
from possible damages by ROS and RNS by a group 
of enzymes, such as, for instance: a katalase, an oxide 
reductase, a superoxide dismutase and glutathione per-
oxidase. At this level, Neisseria must fight also against 
substances secreted by neutrophil cells. These cells, in 
addition to producing antimicrobial peptides, as beta-
defensins, can secrete other compounds as: elastase, 
lactoferrin, and lysozyme [21] N. meningitidis exploits 
many stratagems to evade the actions of these antimicro-
bial molecules, among which is worth citing also LL-37 
peptide, which is secreted by macrophage, and which is 
the unique cathelicidin known until now. Between the 
r. gaspariNi et al.
52
different components of the outer membrane, lipopoly-
saccharide plays an important role in protecting the bac-
terial cell. Indeed, in particular, through a slight change 
in its chemical composition and therefore in its steric 
conformation, it can escape to neutralization action of 
antimicrobial compounds and so it can help to confer 
Neisseria resistance against antimicrobial peptides and 
proteins. However, the major system of bacterial defence 
is the capsule. Probably, the capsule due to its steric con-
formation prevents the antimicrobial peptides to reach 
the outer membrane of the bacterium. Remarkably, N. 
meningitidis also has an efflux pump, that appears very 
important for antimicrobial-protein resistance, since, as 
already said, antimicrobial proteins appears to act both 
modifying bacterial membrane stability and permeabil-
ity and further inside the bacterial cells.
In addition, N. meningitidis secretes 2 proteins involved 
in iron metabolism, which is particularly important for 
bacterial growth. These 2 proteins, lactoferrin binding 
proteins A an B, are able to subtract the chelated iron 
from lactoferrin, making it available for the vital needs 
of the bacterium.
How N. meningitidis spreads  
and can survive in the bloodstream?
The same receptors that the meningococcus uses to adhere 
to epithelial cells of the respiratory mucosa are, probably, 
used by the microorganism to cross the endothelium from 
the capillaries, and invade the bloodstream.
In the bloodstream the microorganism is widely exposed 
to numerous immune mechanisms of defence, especially 
to the complement system. In particular, the production 
of proinflammatory cytokines produced by phagocytes, 
cause an inflammation which increases the chances of 
the bacterium to cross the endothelial barrier.
The complement system can be activated through 3 
pathways. All the mechanisms of activation of the com-
plement system converge in the nodal point of covalent 
attachment of C3b factor. C3b activation allows to reach 
three goals, such as: the processing antigen, for adapta-
tive cellular and humoral immunity, C5b-9 activation, 
for disruption of bacterium membrane, and phagocyto-
sis, for pathogen killing [22].
Each of the 3 pathways has its own specific focus. The 
classical pathway has its primary target in the antigen-
antibody complexes, but also it recognizes certain 
pathogen-associated molecular patterns (PAMPs) as 
polysaccharides on the surface of microorganisms. The 
primary target of alternative pathway is any non-self 
molecular pattern of the human body. The mechanisms 
of recognition is based on a family of proteins named 
factor H. However, recently, it has been demonstrated 
that the protein named properdin is able to activate the 
alternative pathway, also when it is necessary to destroy 
apoptotic and necrotic human cells [23].
The last mechanism of complement activation is the 
Lectin pathway, which acts through several proteins, as, 
for instance, MBL (mannose-binding lectin) and ficol-
ins [24].
Thanks to several mechanisms, N. meningitidis can es-
cape from the complement system. One of these is its 
molecular mimicry of human structures (for instance, the 
meningococcus B polysaccharide capsule is constituted 
by poly-sialic acid, which is present in many mammali-
an organs during development), in this way correspond-
ent antibodies do not can be produced and the classical 
pathway do not can be activated [25]. The capsule is the 
most important bacterial structure in the prevention of 
bacterium lysis, mediated by the complement system 
and by phagocytosis.
Further, N. meningitidis secerns a lot of blebs, contain-
ing outer membrane components, lipopolysaccharide 
included. In this way the microorganism can steer away 
from its self the defensive mechanisms, including the 
complement system [26].
Lipo-polysaccharide is a part of all Gram-negative bac-
teria, and it is fundamental in the machinery of the bac-
teria to resist to complement action [27].
In addition, N. meningitidis expresses a protein, fHbp 
(factor H binding protein) that captures the factor H, and 
consequently can block the alternative pathway activa-
tion. Factor H binding protein is a lipoprotein expressed 
on the surface of the microorganism [28]. Further, an-
other surface protein, called neisserial surface protein 
A (NspA), able to bind human factor H (fH) has been 
detected [29].
Another protein which can help meningococci to escape 
from complement system is a lipoprotein named NHBA 
(Neisserial Heparin Binding Antigen) [30]. Although the 
function of this protein it is not yet completely known, 
however, this antigen expressed on the surface of the 
most part of N. meningitidis appears to capture heparan-
sulfate molecules contributing to defend the bacterial 
cells against complement system. Furthermore, it is pos-
sible that NHBA contribute to the adesion mecchanisms 
to human cells, indeed OPC mediates the adhesion and 
invasion by vitronectin, and integrins, and mediation 
with vitronectin requires heparin.
In the bloodstream N. meningitidis stimulates cytokine 
release from phagocytic, lymphocytic and endothelial 
cells. One of the consequences of this release is the 
damage that leads to clinical symptoms, and, particu-
larly to petechial rash. LPS, too, contributes to endothe-
lial damage [31] (Fig. 1). LPS can also contribute to the 
activation of the coagulation system, up regulating the 
tissue factor. Abnormal activation of the coagulation 
system can provoke a disseminated intravascular coagu-
lation (DIC), and the Waterhause-Friederiksen’s syn-
drome [32]. It is possible that the DIC could be facilitate 
by NHBA too, which captures glycosaminoglycans (e.g. 
heparan sulfate) [30].
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How N. meningitidis reaches 
Leptomeninges?
N. meningitidis can located it self in the leptomeninges 
adhering both to endothelial cells and to cuboid cells of 
choriod plexus. Low blood flow facilitates the adhesion, 
that is mediated by pili system [8]. However, also, Opa 
proteins, and especially, Opc, can contribute to adhesion 
and penetration of meningococcus into the cells of the 
leptomeninges [33].
It is important to note that, probably, the most important 
mechanism of crossing the Blood-Brain-Barrier (BBB) 
is the passage of meningococci through the junctions of 
endothelial cells [34], and the process of internalization 
of the bacterium in the endothelial cells (transcytose), 
although demonstrated, plays a minor role. Indeed, par-
ticularly, pro-inflammatory cythokines induced by LPS, 
through a cytopathic effect on endothelial cells, can help 
meningococci to cross the BBB, probably and overall, 
through the disruption of intercellular junctions. Higher 
Fig. 1. the main components of the structure of N. meningitidis are:
Capsule: it is composed of polysaccharides containing sialic acid, which favor the mimicry which weakens the immune response;
The lipo-oliogosaccaride (LPS): the lps is extremely variable. lps can bind sialic acid, which helps the camouflage of the meningococcus. 
lipoligosaccaride plays a crucial role in determining meningococcal sepsis. the lps induces the formation of various cytokines that cause 
vascular endothelial damage, leading to necrosis and severe damage in many organs and systems. lps causes the release of il6 and tNF, 
rOs and NO, acting also through the tlr-4;
Lactoferrin binding proteins A and B: Neisseria expresses two superficial proteins named lactoferrin binding proteins a and B, which can 
bound iron which is an essential growth factor during bacterial colonization;
Porins: pora and porB are part of neisserial outer membrane and contribute to the mechanism of adhesion of bacteria to the cells, porin 
a also bind a regulatory protein of the complement;
Pili: the pili are the most important mechanism of adhesion of Neisseriae to the cells. the most important of the 3 known pilins is pilin e;
Opa and Opc: Neisseriae express 2 types of outer-membrane proteins, which give opacity to the colonies of meningococcus growth in 
agar plate. these proteins are involved in adhesion mechanisms, recognizing the CeaCam receptor. Opa also recognize another surface 
receptor hspgs. OpC also mediates the adhesion and invasion by vitronectin, and integrins. mediation with vitronecnin requires heparin; 
Minor adhesins: Other adhesins are: Nad a, OCa, Nhha and the app;
fHbp: fhbp bounds complement factor h, and in this manner promotes the resistance of the organism in the blood stream.
Structure of N. meningitidis
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levels of IL-6 and -8, and a low level of chemokines (for 
instance CCL5), were found, in experimental studies to 
favour the adhesion of N. meningitidis on meningioma 
cells, comparing it with N. lactamica [35, 36].
Probably, also, minor adhesins are involved in the mech-
anism of adhesion and penetration of the bacterium in 
endothelial and in pia mater and arachnoid cells. 
Conclusions
In conclusion, Neisseria meningitidis has developed a 
formidable machinery to survive in its unique biologi-
cal niche that man. Five fundamental pillars support this 
adaptation, ie the capsule, the lipopolysaccharide, the 
groups of proteins that allow to block the action of the 
antimicrobial proteins, proteins that inhibit the comple-
ment system and components that prevent both the mat-
uration and the perfect functioning of phagocytes. If the 
capsule and LPS appear as the main features of hyper-
virulent strains, other mechanisms allow the bacterium 
to survive, albeit for short periods, as a commensal in the 
nasopharynx. If the first contacts with the meningococci 
are the most dangerous, because they can more easily 
lead to illness, the particular habits of young people as-
sociated with a decline in immune protection typical of 
their age, make that young people are the main reservoir 
of Neisseria meningitidis.
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